Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 28384 | 169 | 34.1 | 83% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 994 | 9968 | IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//PULMONARY ALVEOLAR PROTEINOSIS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PIRFENIDONE | Author keyword | 34 | 40% | 40% | 68 |
| 2 | FLUOROFENIDONE | Author keyword | 15 | 73% | 7% | 11 |
| 3 | AKF PD | Author keyword | 6 | 100% | 2% | 4 |
| 4 | STATE MED GENET CHINA | Address | 3 | 27% | 7% | 11 |
| 5 | BIOL MOL MED TER IA GEN | Address | 1 | 33% | 2% | 3 |
| 6 | ANTIFIBROTIC DRUG | Author keyword | 1 | 50% | 1% | 1 |
| 7 | CARBOHYDRATE MODIFIED | Author keyword | 1 | 50% | 1% | 1 |
| 8 | ENDOTOXIN INDUCED LIVER INJURY | Author keyword | 1 | 50% | 1% | 1 |
| 9 | FIBROGENIC ACTIVITY | Author keyword | 1 | 50% | 1% | 1 |
| 10 | GALN | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PIRFENIDONE | 34 | 40% | 40% | 68 | Search PIRFENIDONE | Search PIRFENIDONE |
| 2 | FLUOROFENIDONE | 15 | 73% | 7% | 11 | Search FLUOROFENIDONE | Search FLUOROFENIDONE |
| 3 | AKF PD | 6 | 100% | 2% | 4 | Search AKF+PD | Search AKF+PD |
| 4 | ANTIFIBROTIC DRUG | 1 | 50% | 1% | 1 | Search ANTIFIBROTIC+DRUG | Search ANTIFIBROTIC+DRUG |
| 5 | CARBOHYDRATE MODIFIED | 1 | 50% | 1% | 1 | Search CARBOHYDRATE+MODIFIED | Search CARBOHYDRATE+MODIFIED |
| 6 | ENDOTOXIN INDUCED LIVER INJURY | 1 | 50% | 1% | 1 | Search ENDOTOXIN+INDUCED+LIVER+INJURY | Search ENDOTOXIN+INDUCED+LIVER+INJURY |
| 7 | FIBROGENIC ACTIVITY | 1 | 50% | 1% | 1 | Search FIBROGENIC+ACTIVITY | Search FIBROGENIC+ACTIVITY |
| 8 | GALN | 1 | 50% | 1% | 1 | Search GALN | Search GALN |
| 9 | SMADS PATHWAY | 1 | 50% | 1% | 1 | Search SMADS+PATHWAY | Search SMADS+PATHWAY |
| 10 | TANDOM MASS SPECTROMETRY | 1 | 50% | 1% | 1 | Search TANDOM+MASS+SPECTROMETRY | Search TANDOM+MASS+SPECTROMETRY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTIFIBROTIC AGENT | 18 | 56% | 13% | 22 |
| 2 | BLEOMYCIN HAMSTER MODEL | 9 | 32% | 14% | 24 |
| 3 | TRANSLATIONAL LEVEL | 4 | 38% | 5% | 8 |
| 4 | ANTI FIBROTIC AGENT | 3 | 60% | 2% | 3 |
| 5 | PIRFENIDONE | 2 | 10% | 12% | 20 |
| 6 | TRANSCRIPTIONAL LEVEL | 2 | 18% | 6% | 10 |
| 7 | ANTIGEN INDUCED INCREASES | 1 | 50% | 1% | 1 |
| 8 | MICE HIPPOCAMPUS | 1 | 50% | 1% | 1 |
| 9 | OBSTRUCTED KIDNEY | 1 | 50% | 1% | 1 |
| 10 | RENAL TRANSPLANT BIOPSIES | 1 | 50% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Pirfenidone In Idiopathic Pulmonary Fibrosis | 2011 | 22 | 22 | 59% |
| Pirfenidone: Anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients | 2006 | 13 | 17 | 65% |
| Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives | 2015 | 2 | 104 | 9% |
| Pirfenidone treatment of idiopathic pulmonary fibrosis | 2011 | 7 | 55 | 31% |
| Investigational approaches to therapies for idiopathic pulmonary fibrosis | 2010 | 7 | 79 | 18% |
| Prevention of progressive fibrosis in chronic renal diseases: Antifibrotic agents | 2004 | 43 | 55 | 11% |
| Novel treatments for hepatitis C viral infection and the hepatic fibrosis | 2009 | 0 | 46 | 9% |
| Colorectal carcinoma: Importance of colonic environment for anti-cancer response and systemic immunity | 2009 | 6 | 80 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | STATE MED GENET CHINA | 3 | 27% | 6.5% | 11 |
| 2 | BIOL MOL MED TER IA GEN | 1 | 33% | 1.8% | 3 |
| 3 | NEPHROL PEOPLES LIBERAT ARMY | 1 | 50% | 0.6% | 1 |
| 4 | PHARAMACOL | 1 | 50% | 0.6% | 1 |
| 5 | WOMENS ONCOL EXPT THER EUT | 1 | 50% | 0.6% | 1 |
| 6 | ZHONGSHAN OPHTHALM STATE OPHTHALMOL | 1 | 50% | 0.6% | 1 |
| 7 | PHARMACEUT DISCOVERY S 1 | 0 | 33% | 0.6% | 1 |
| 8 | MOL BIOL MED GENE THER Y | 0 | 11% | 1.8% | 3 |
| 9 | CHRON ILLNESS DISABIL | 0 | 25% | 0.6% | 1 |
| 10 | FRONTIER DRUG DISCOVERY | 0 | 25% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000247644 | IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//IDIOPATHIC INTERSTITIAL PNEUMONIA |
| 2 | 0.0000181445 | HSP47//HEAT SHOCK PROTEIN 47//UMB GREENEBAUM CANC |
| 3 | 0.0000123394 | BLEOMYCIN//PULMONARY FIBROSIS//LUNG FIBROSIS |
| 4 | 0.0000112687 | FIBROCYTES//FIBROCYTE//RENAL FIBROSIS |
| 5 | 0.0000075143 | TRANILAST//CORONARY ARTERY ENDOTHELIAL CELL//HUMAN TENONS CAPSULE FIBROBLAST |
| 6 | 0.0000061461 | RUBOXISTAURIN//PENN MOL STUDIES KIDNEY DIS//BEETHAM EYE OPHTHALMOL |
| 7 | 0.0000054866 | HERMANSKY PUDLAK SYNDROME//CHEDIAK HIGASHI SYNDROME//LYST |
| 8 | 0.0000053475 | VICTORIA JOHNSON//VCU PAULEY HEART//VICTORIA JOHNSON S |
| 9 | 0.0000052234 | UNILATERAL URETERAL OBSTRUCTION//PARTIAL URETERAL OBSTRUCTION//OBSTRUCTIVE NEPHROPATHY |
| 10 | 0.0000048796 | CTHRC1//COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1//CAROTID ARTERY RESTENOSIS |